NEW YORK (360Dx) – Spanish diagnostics firm Biohope is about to commence a large-scale study of its flagship Immunobiogram in vitro diagnostic for determining the best immunosuppressive treatment for patients undergoing kidney transplantation.

The €3.8 million ($4.5 million) project, called Transbio, has been funded through the EU's Horizon 2020 program and will run through 2019. Biohope recently completed a pilot phase of the two-year study in partnership with two Spanish hospitals that yielded positive results.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.